Sequoia Financial Advisors LLC Buys 102 Shares of The Clorox Company (NYSE:CLX)

Sequoia Financial Advisors LLC raised its stake in The Clorox Company (NYSE:CLX) by 2.5% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 4,228 shares of the company’s stock after buying an additional 102 shares during the period. Sequoia Financial Advisors LLC’s holdings in Clorox were worth $689,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in CLX. Wealthcare Advisory Partners LLC bought a new position in Clorox during the 1st quarter worth approximately $242,000. LVW Advisors LLC bought a new position in Clorox during the first quarter worth $247,000. Successful Portfolios LLC acquired a new position in Clorox in the first quarter valued at $211,000. Aviance Capital Partners LLC bought a new stake in Clorox during the first quarter valued at $459,000. Finally, Diversified Trust Co grew its holdings in Clorox by 54.8% during the 1st quarter. Diversified Trust Co now owns 13,054 shares of the company’s stock worth $1,999,000 after acquiring an additional 4,623 shares during the period. Institutional investors and hedge funds own 78.53% of the company’s stock.

Insider Buying and Selling at Clorox

In related news, EVP Angela C. Hilt sold 1,733 shares of the business’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the transaction, the executive vice president now directly owns 13,471 shares of the company’s stock, valued at approximately $2,229,719.92. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.51% of the company’s stock.

Clorox Stock Performance

NYSE CLX opened at $156.69 on Friday. The company has a fifty day moving average price of $160.74 and a 200-day moving average price of $145.61. The firm has a market cap of $19.46 billion, a price-to-earnings ratio of 81.19, a PEG ratio of 3.19 and a beta of 0.41. The company has a debt-to-equity ratio of 5.04, a current ratio of 1.03 and a quick ratio of 0.63. The Clorox Company has a 1 year low of $114.68 and a 1 year high of $169.09.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Thursday, August 1st. The company reported $1.82 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.54 by $0.28. Clorox had a net margin of 3.95% and a return on equity of 281.12%. The business had revenue of $1.90 billion during the quarter, compared to the consensus estimate of $1.97 billion. As a group, equities research analysts predict that The Clorox Company will post 6.64 EPS for the current fiscal year.

Clorox Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, November 7th. Shareholders of record on Wednesday, October 23rd will be given a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, October 23rd. This represents a $4.88 annualized dividend and a yield of 3.11%. Clorox’s dividend payout ratio is currently 252.85%.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on the company. Wells Fargo & Company dropped their price objective on Clorox from $135.00 to $130.00 and set an “underweight” rating on the stock in a research note on Wednesday, July 10th. Barclays increased their price target on Clorox from $130.00 to $137.00 and gave the stock an “underweight” rating in a report on Friday, October 11th. Evercore ISI lowered their price objective on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research note on Monday, October 14th. Citigroup boosted their target price on shares of Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a research report on Friday, September 6th. Finally, Jefferies Financial Group upgraded shares of Clorox from a “hold” rating to a “buy” rating and raised their price target for the stock from $174.00 to $187.00 in a report on Tuesday, October 1st. Six equities research analysts have rated the stock with a sell rating, nine have given a hold rating and one has assigned a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $150.14.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.